Teva and Energetic Biotech are concentrating on analyzing the CHMP's review and will continue steadily to liaise closely with the EMA in working to make NERVENTRA available as a fresh treatment option for sufferers with RRMS in European countries.. Active Biotech, Teva remain focused on NERVENTRA clinical development program for multiple sclerosis Teva Pharmaceutical Sectors Ltd. In accordance with European regulations, Teva and Active Biotech intend to request a re-examination of the CHMP opinion.John Daugirdas, a nephrologist and medical professor at the University of Illinois, Chicago, wrote in an accompanying editorial that the results are intriguing but at this point, it is not at all obvious what the physiology of increased mortality risk associated with taller stature may be, nor how this new knowledge might affect clinical practice. .. ATS receives US $10.7 million in orders from one of the world’s largest medical device companies ATS Automation Tooling Systems has announced it has received a total of US $10.7 million in orders in one of the world’s largest manufacturers of self-use medical diagnostic systems. This brings the worthiness of orders for automation systems ATS provides won in the last year from this particular consumer to more than US $21 million.